Two Sigma Investments’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
Two Sigma Investments's SOPH Position: Q2 2026 in Review
Two Sigma Investments increased its SOPHiA GENETICS (SOPH) stake by 472% in Q2 2026, buying an estimated $244K and bringing the position to 58,333 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #4453.
Two Sigma Investments first reported a position in SOPH in Q2 2022 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Two Sigma Investments held 58,333 shares of SOPHiA GENETICS worth $337K as of Q2 2026.
- Two Sigma Investments bought 48,135 SOPHiA GENETICS shares in Q2 2026, an estimated $244K.
- SOPHiA GENETICS made up ﹤0.01% of Two Sigma Investments's portfolio in Q2 2026, its #4453 holding.
- Two Sigma Investments first reported a position in SOPHiA GENETICS in Q2 2022 and has held it in 3 quarters since.
- 71 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.